Načítá se...
Monitoring the treatment outcome in endometrial cancer patients by CEA and TATI
An attempt was made to compare the usefulness of determining markers carcinoembryonic antigen (CEA) and tumor-associated trypsin inhibitor (TATI) in endometrial cancer patients in whom recurrence or distant metastasis was diagnosed in observation after treatment. The study included 316 patients aged...
Uloženo v:
| Vydáno v: | Tumour Biol |
|---|---|
| Hlavní autoři: | , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Springer Netherlands
2016
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4990607/ https://ncbi.nlm.nih.gov/pubmed/26779635 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s13277-016-4784-9 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|